Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bujamin H Vokshi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Trends in Immunology|July 27, 2024
Mutant ARID1A: igniting cancer immunotherapyBujamin H Vokshi, Eneda Toska
Cell Reports|April 13, 2025
TFE3 fusion oncoprotein condensates drive transcriptional reprogramming and cancer progression in translocation renal cell carcinomaChoon Leng So, Ye Jin Lee, Bujamin H Vokshi, et al.
Cell Reports|November 4, 2023
Super-enhancer-driven expression of BAHCC1 promotes melanoma cell proliferation and genome stabilityPietro Berico, Maguelone Nogaret, Max Cigrang, et al.
Nature Communications|May 26, 2023
SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistanceBujamin H Vokshi, Guillaume Davidson, Nassim Tawanaie Pour Sedehi, et al.
Cell Reports|May 3, 2024
Methylation of the chromatin modifier KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancerRyan Blawski, Bujamin H Vokshi, Xinyu Guo, et al.
Cancer Cell|May 4, 2020
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary CarcinomaPavlos Msaouel, Gabriel G Malouf, Xiaoping Su, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Trends in Immunology|July 27, 2024
Mutant ARID1A: igniting cancer immunotherapyBujamin H Vokshi, Eneda Toska
Cell Reports|April 13, 2025
TFE3 fusion oncoprotein condensates drive transcriptional reprogramming and cancer progression in translocation renal cell carcinomaChoon Leng So, Ye Jin Lee, Bujamin H Vokshi, et al.
Cell Reports|November 4, 2023
Super-enhancer-driven expression of BAHCC1 promotes melanoma cell proliferation and genome stabilityPietro Berico, Maguelone Nogaret, Max Cigrang, et al.
Nature Communications|May 26, 2023
SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistanceBujamin H Vokshi, Guillaume Davidson, Nassim Tawanaie Pour Sedehi, et al.
Cell Reports|May 3, 2024
Methylation of the chromatin modifier KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancerRyan Blawski, Bujamin H Vokshi, Xinyu Guo, et al.
Cancer Cell|May 4, 2020
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary CarcinomaPavlos Msaouel, Gabriel G Malouf, Xiaoping Su, et al.
Pageof 1